Evogene

Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence. .

Evogene Ltd.
Public
Traded asTASE: EVGN
NYSE: EVGN
IndustryComputational Biology
Founded2002
FounderDr. Hagai Karchi and Dr. Rafi Meissner
HeadquartersRehovot, Israel
Key people
Martin Gerstel, Chairman of Board, Ofer Haviv, President & CEO
SubsidiariesBiomica, Canonic, Lavie Bio, AgPlenus, Castera
Websitewww.evogene.com

Technology

Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products.

Subsidiaries

Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

References
  1. Corteva Agriscience and AgPlenus Announce Collaboration for the Development of Novel Herbicides
  2. Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127 for its Immuno-Oncology Program
  3. Canonic Announces Initiation of Cultivation and Breeding of Cannabis Varieties with Unique Genomic Profiles for the Development of Medical Cannabis Products
  4. Corteva Agriscience to Invest in Evogene’s Agriculture Biologicals Subsidiary, Lavie Bio
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.